
### [NCIT:C5545](http://purl.obolibrary.org/obo/NCIT_C5545)
**Label:** Prostate Neuroendocrine Neoplasm

**Subclasses:** [NCIT:C6766](http://purl.obolibrary.org/obo/NCIT_C6766) (Prostate Small Cell Carcinoma), [NCIT:C5024](http://purl.obolibrary.org/obo/NCIT_C5024) (Prostate Carcinoid Tumor), 

**Class expressions from DL-Learner:**

- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) 55.00%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 55.00%
- [UBERON:0000077](http://purl.obolibrary.org/obo/UBERON_0000077) (mixed endoderm/mesoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 55.00%
- Thing 52.53%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 40.36%
- [UBERON:0004120](http://purl.obolibrary.org/obo/UBERON_0004120) (mesoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40122](http://purl.obolibrary.org/obo/NCIT_C40122) (Pelvic Pain))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 40.36%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 40.36%


